Abstract: A 67-year-old woman was referred for staging of a mucosa-associated lymphoid tumor lymphoma involving the left conjunctiva. CT scan had shown paravertebral and pelvic masses, and a breast nodule. FDG PET/CT demonstrated moderately increased uptake in the left ocular conjunctiva and confirmed the paravertebral and pelvic masses and the breast nodule. Moreover, abnormal FDG uptake was shown in 2 breast nodules, the flank, the gluteus maximus, and the gastric cardia. The patient received 6 cycles of rituximab-bendamustine chemotherapy with a complete clinical and metabolic response at the 6-month follow-up PET/CT and remained relapse-free without visual acuity problem after a 36-month follow-up.
From the Departments of *Nuclear Medicine, †Oncology, and ‡Hematology, Lausanne University Hospital; §Jules Gonin Eye Hospital; ¶Department of Pathology, Lausanne University Hospital, Lausanne; and ∥Department of Oncology, Sion Hospital, Sion, Switzerland.
Received for publication July 8, 2013; revision accepted December 11, 2013.
Conflicts of interest and sources of funding: none declared.
Reprints: John O. Prior, PhD, MD, Department of Nuclear Medicine, Lausanne University Hospital, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland. E-mail: email@example.com.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/3.0.